DPP-4 inhibitors, known as gliptins, are a class of oral diabetic medications approved by the Food and Drug Administration (FDA) to treat type 2 diabetes mellitus in adults. DPP-4 inhibitors that have FDA approval include sitagliptin, saxagliptin, linagliptin, and alogliptin.
People also ask
What drugs are dipeptidyl peptidase 4 inhibitors?
What is the mechanism of action of DPP-4 inhibitors?
What are the benefits of DPP-4 inhibitors?
What is the role of dipeptidyl peptidase 4 inhibitors in the new era of antidiabetic treatment?
scholar.google.com › citations
Feb 22, 2016 · DPP-4 inhibitors are a class of prescription medicines that are used with diet and exercise to control high blood sugar in adults with type ...
DPP-4 inhibitors, such as sitagliptin and saxagliptin, slow the inactivation and degradation of GLP-1, offering the newest FDA-approved treatment approaches for ...
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of medicine that lower high blood glucose levels and may be used in the treatment of type 2 diabetes.
Apr 27, 2023 · Dipeptidyl peptidase 4 (DPP-4) inhibitors for the treatment of type 2 diabetes mellitus. Formulary drug information for this topic.
Aug 28, 2015 · Severe and disabling joint pain has been reported with the use of dipeptidyl peptidase-4 (DPP-4 inhibitors). The time to onset of symptoms ...
DPP-4 inhibitors work by blocking the action of DPP-4, an enzyme which destroys the hormone incretin. Incretins help the body produce more insulin only when ...
People also search for
Related health topics
For informational purposes only. Consult your local medical authority for advice.